Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 2,020 | 1,963 | 0 | 0 |
| Operating Income | -2,020 | -1,963 | N/A | N/A |
| Interest Expense | 244 | 139 | 0 | 0 |
| Other Income | 0 | -63 | 0 | 0 |
| Pre-tax Income | -2,264 | -2,165 | 0 | 0 |
| Net Income Continuous | -2,264 | -2,165 | N/A | N/A |
| Net Income | $-2,264 | $-2,165 | $N/A | $N/A |
| EPS Basic Total Ops | -2.70 | -2.70 | N/A | N/A |
| EPS Basic Continuous Ops | -2.66 | -2.67 | N/A | N/A |
| EPS Diluted Total Ops | -2.70 | -2.70 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.66 | -2.67 | N/A | N/A |
| EBITDA(a) | $-1,834 | $-1,867 | $N/A | $N/A |